⚠️ Millions of tokens unlocking? A short-selling opportunity you cannot miss!
Today, two tokens will see a massive unlocking — the modular blockchain project Avail (AVAIL) and the emerging Layer2 platform SOON will simultaneously launch large-scale token unlocks, with a total exceeding 1 billion tokens.
💠Avail
Will release 972.85 million tokens at once (accounting for 38.23% of the circulating supply), valued at approximately $18.9 million, with 500 million tokens allocated to the core team and 353 million tokens flowing to institutional investors.
This unlocking accounts for 57.99% of its unlockable supply and is a one-time release (Cliff Unlock), which will instantly impact market liquidity.
‼️ This is Avail's first unlocking! Historical experience tells us that such “first times” are often the most “bloody” — early investors and the team have held back for so long, and now that the tokens can finally move, those “selling to improve life” little thoughts, you know what I mean?
Think about it, now the entire market cap of AVAIL is only around $500 million, and suddenly nearly 40% of “new goods” are flooding in, the price pressure in the short term feels like climbing a mountain with an elephant on your back.
💠Soon
Will unlock 41.88 million tokens (accounting for 22.41% of the circulating supply), valued at approximately $6.1 million.
‼️ Does the unlocking amount seem smaller? But don’t forget, its fully diluted valuation (FDV) is as high as $900 million, and if the TVL is less than $5 million after the mainnet goes live, the FDV/TVL ratio will exceed 18 times, much more “expandable” than those established L2s like Optimism and Arbitrum.
Meanwhile, on July 5, SOON experienced a “highly coordinated sell-off attack,” causing a flash crash in coin price. Although the project party denies that the team and market makers were involved, market confidence has already been severely damaged. Guess whether the team will support the price this time or just let it drop first?
The above is purely personal chatter, not investment advice, please DYOR.